Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

IDX/EPMT stock hub

IDX/EPMT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/EPMTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.4T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/EPMT

In the news

Latest news · IDX/EPMT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E8.3

P25 11.5P50 23.8P75 52.6

ROE9.7

P25 0.6P50 5.1P75 12.2

ROIC10.2

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/EPMT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

IDR

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	5,102
Employees Change	-22%
Employees Change Percent	-0.43
Enterprise value	IDR 6.3T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Distribution
Isin	ID1000096506
Last refreshed	2026-05-10
Market cap	IDR 6.4T
Price	IDR 2,370
Price currency	IDR
Rev Per Employee	6,607,205,729.16x
Sector	Healthcare
Sic	5122
Symbol	idx/EPMT
Website	https://www.enseval.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.09%
EV Earnings	8.07x
EV/EBIT	6.08x
EV/EBITDA	5.11x
EV/FCF	9.94x
EV/Sales	0.19x
FCF yield	9.8%
P/B ratio	0.79x
P/E ratio	8.27x
P/S ratio	0.19x
PE Ratio10 Y	9.8x
PE Ratio3 Y	8.9x
PE Ratio5 Y	8.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.03%
EBITDA Margin	3.56%
FCF margin	1.87%
Gross margin	9.63%
Gross Profit	IDR 3.2T
Gross Profit Growth	6.44%
Gross Profit Growth Q	2.82%
Gross Profit Growth3 Y	3.41%
Gross Profit Growth5 Y	5.35%
Net Income	IDR 775.8B
Net Income Growth	4.3%
Net Income Growth Q	-4.77%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	-3.17%
Net Income Growth5 Y	1.05%
Pretax Margin	3.01%
Profit Margin	2.3%
Profit Per Employee	IDR 152.1M
Profitable Years	15
ROA	4.77
Roa5y	5.9
ROCE	12.34
ROE	9.7
Roe5y	10.87
ROIC	10.24
Roic5y	12.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.12%
Cagr15y	11.25%
Cagr1y	7.04%
Cagr20y	9.05%
Cagr3y	0.14%
Cagr5y	8.24%
Div CAGR10	43.02%
Div CAGR3	-4.42%
Div CAGR5	14.74%
EPS Growth	4.3
EPS Growth Q	-4.77
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	-3.17
EPS Growth5 Y	1.05
FCF Growth	58.84%
FCF Growth5 Y	1.14%
OCF Growth	53.3%
OCF Growth10 Y	6.01%
OCF Growth5 Y	2.9%
Revenue Growth	7.74x
Revenue Growth Q	9.02x
Revenue Growth Quarters	9x
Revenue Growth Years	14x
Revenue Growth3 Y	5.8x
Revenue Growth5 Y	8.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 2.52
Assets	IDR 14.1T
Cash	IDR 456.1B
Current Assets	IDR 12.2T
Current Liabilities	IDR 5.8T
Debt	IDR 249.3B
Debt EBITDA	IDR 0.2
Debt Equity	IDR 0.03
Debt FCF	IDR 0.4
Equity	IDR 8.1T
Interest Coverage	76.7
Liabilities	IDR 6T
Long Term Assets	IDR 1.9T
Long Term Liabilities	IDR 146.6B
Net Cash	IDR 206.8B
Net Cash By Market Cap	IDR 3.22
Net Cash Growth	38.65%
Net Debt EBITDA	IDR -0.17
Net Debt Equity	IDR -0.03
Net Debt FCF	IDR -0.33
Tangible Book Value	IDR 8.1T
Tangible Book Value Per Share	IDR 2,982
WACC	4.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.09
Inventory Turnover	6.29
Net Working Capital	IDR 6.1T
Quick ratio	1.09
Working Capital	IDR 6.3T
Working Capital Turnover	IDR 5.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	7.83%
Dividend Growth Years	1%
Dividend per share	IDR 179
Dividend Years	11
Dividend Yield	7.55%
Ex Div Date	2025-06-03
Last Dividend	IDR 179
Payout Frequency	Annual
Payout Ratio	62.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	35.94%
1Y total return	7.04%
200-day SMA	2,314
3Y total return	0.41%
50-day SMA	2,338
50-day SMA vs 200-day SMA	50over200
5Y total return	48.53%
All Time High	4,000
All Time High Change	-40.75%
All Time High Date	2013-12-19
All Time Low	3.5
All Time Low Change	67,653%
All Time Low Date	1998-09-16
ATR	40.03
Beta	0
Beta1y	0.02
Beta2y	0.22
Ch YTD	3.04
High	2,400
High52	2,600
High52 Date	2025-06-02
High52ch	-8.85%
Low	2,360
Low52	2,200
Low52 Date	2025-10-13
Low52ch	7.73%
Ma50ch	1.37%
Price vs 200-day SMA	2.42%
RSI	53.54
RSI Monthly	49.38
RSI Weekly	58.31
Sharpe ratio	0.91x
Sortino ratio	1.96
Total Return	7.55%
Tr YTD	3.04
Tr15y	394.78%
Tr1m	1.72%
Tr1w	-0.84%
Tr3m	3.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 1T
Operating Income Growth	4.9
Operating Income Growth Q	-3.71
Operating Income Growth3 Y	-2.31
Operating Income Growth5 Y	3.84
Operating margin	3.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	217,354,205%
Net Borrowing	29,228,174,833
Shares Out	2,708,640,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 629.4B
Average Volume	81,330x
Bv Per Share	2,986.9
CAPEX	IDR -217B
Ch10y	-13.82
Ch15y	189
Ch1m	1.72
Ch1w	-0.84
Ch1y	-0.42
Ch20y	182.1
Ch3m	3.04
Ch3y	-18.84
Ch5y	3.04
Ch6m	0.85
Change	-1.25%
Change From Open	-1.25
Close	2,400
Days Gap	0
Depreciation Amortization	178,782,258,224
Dollar Volume	228,231,000
Earnings Date	2026-07-30
EBIT	IDR 1T
EBITDA	IDR 1.2T
EPS	IDR 286
F Score	5
FCF	IDR 629.4B
FCF EV Yield	10.06x
FCF Per Share	IDR 232
Financing CF	-476,446,482,531
Fiscal Year End	December
Founded	1,973
Graham Number	4387.35191
Graham Upside	85.12
Income Tax	IDR 237.8B
Investing CF	-271,171,236,961
Is Primary Listing	1
Last Earnings Date	2025-10-29
Last Report Date	2026-03-31
Last Split Date	2003-12-11
Last Split Type	Forward
Lynch Fair Value	IDR 1,432
Lynch Upside	-39.57
Ma150	2,318.2
Ma150ch	2.23%
Ma20	2,365
Ma20ch	0.21%
Net CF	101,819,563,788
Next Earnings Date	2026-07-30
Open	2,400
P FCF Ratio	10.2
P OCF Ratio	7.58
Payment Date	2025-06-20
Position In Range	25
Ppne	1,589,388,395,826
Price Date	2026-05-08
Price EBITDA	IDR 5.35
Ptbv Ratio	0.79
Relative Volume	1.2x
Revenue	33,709,963,630,150x
Tax By Revenue	0.71x
Tax Rate	23.47%
Tr20y	465.73%
Tr6m	0.85%
Volume	96,300
Z Score	4.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IDX/EPMT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.6%

$179 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.7%

1 consecutive years of growth

Total shareholder yield

+7.6%

Next ex-dividend date: 2025-06-03

Performance

IDX/EPMT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

IDX/EPMT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.5

Neutral momentum band

Price vs 200-day MA

+2.4%

50/200-day relationship not available

Beta (5Y)

0.00

Less volatile than the market

Sharpe ratio

0.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/EPMT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/EPMT stock rating?

idx/EPMT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/EPMT analysis?

The full report lives at /stocks/idx/EPMT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/EPMT?

The latest report frames idx/EPMT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/EPMT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.